Table 2b The correlation between composite ratios and cumulative scores and clinicopathological characteristics of patients undergoing elective surgery for colon cancer (n = 689)

	Age	Sex	BMI	ASA grade	T stage	N stage	Differentiation	Venous invasion	Margin involvement	Peritoneal involvement	Tumour perforation	Adjuvant therapy
NLR	0.009	0.398	<0.001	0.156	0.069	0.287	0.018	0.002	0.219	0.195	<0.001	0.063
NLS	0.002	0.746	0.003	0.880	0.039	0.504	0.073	0.078	0.069	0.062	0.004	0.301
PLR	<0.001	0.391	<0.001	0.294	0.001	0.395	0.087	0.214	0.095	0.002	0.803	0.758
PLS	0.008	0.827	<0.001	0.337	0.001	0.449	0.029	0.002	0.012	0.005	0.043	0.907
LMR	<0.001	0.004	0.030	0.705	0.063	0.948	0.557	0.133	0.750	0.085	0.041	0.067
LMS	<0.001	0.872	0.165	0.841	0.001	0.412	0.044	0.158	0.033	<0.001	0.184	0.097
NPS	0.649	0.990	0.016	0.753	0.004	0.017	0.005	0.013	0.015	0.277	0.375	0.341
CAR	0.008	0.618	0.027	0.009	<0.001	0.071	0.001	0.011	0.037	0.007	0.004	0.341
mGPS	0.180	0.913	<0.001	0.294	<0.001	0.616	<0.001	0.006	0.005	0.003	0.001	0.422

*p <0.01 is considered significant.
NLR neutrophil–lymphocyte ratio, NLS neutrophil–lymphocyte score, CAR C-reactive protein albumin ratio, mGPS modified Glasgow prognostic score, NPS neutrophil–platelet score, LMS lymphocyte–monocyte score, LMR lymphocyte–monocyte ratio, PLR platelet–lymphocyte ratio, PLS platelet–lymphocyte score

Quick links

Search